跳轉至主要內容

Using AI to identify COVID-19 lesions in lung CT scans

Mike McNamara
Mike McNamara
274 瀏覽

Using AI to identify lung CT scansThe high numbers of hospitalizations and the level of critical care that many COVID-19 patients require can push healthcare institutions and staff to their limits. COVID pneumonia (viral infection in the lungs), which is detected by a chest x-ray or CT scan, can predict the need for more advanced inpatient care.

A busy hospital may perform many lung CTs per day, potentially affecting the service levels that radiology teams are able to deliver. By prescreening the CT scans of COVID-19 patients, an accurate AI model can quickly pinpoint critical results and enable care teams to zero in on patients who are at high risk for severe complications.

Model tuning, testing, and ongoing training are necessary to create and sustain an optimized artificial intelligence model. Careful attention to traceability, reproducibility, and patient privacy are essential.  NetApp and SFL Scientific have developed technology for high-performing COVID-19 lung segmentation that uses a state-of-the-art model and transfer learning. The following image compares human annotations and model prediction of lung lesions in a COVID-19 patient. Our methodology delivers an accurate, trained model in a short time and supports ongoing training and optimization with complete traceability.

Running on a fast and efficient NetApp® storage infrastructure, the model takes an average of just 6 seconds to identify the COVID lesions on each patient scan, which is composed of hundreds of images. This speed is on par with other advanced models and is much faster than a typical human analysis of a chest CT.

Additional AI opportunities

The methodology that NetApp and SFL Scientific used to create a COVID-19 lung segmentation model can be generalized and applied to almost any image segmentation task. With access to the appropriate data, we can help you create AI segmentation models for any organ system, encompassing a wide range of imaging modalities, from simple 2D x-rays to 3D CT and MRI scans to ultrasound. Similar methods can also be applied to digital pathology.

Looking beyond medical imaging, the same approach—combining transfer learning, experimentation, iterative fine tuning, intelligent data management, and production deployment with regular retraining—can be applied to a wide range of computer vision, natural language processing, and other use cases in healthcare and other industries. NetApp and SFL Scientific can help you get your AI project to production more quickly with fewer missteps.

To learn more, read the white paper Deep learning to identify COVID-19 lesions in lung CT scans and watch the on-demand video COVID-19 lung CT lesion segmentation.

COVID-19 Lung CT Lesion Segmentation and Image Pattern Recognition with DL
Learn about a deep learning system that can automatically identify and segment lesions in lung CT images and could reduce the workload of physicians while helping ease the burden on the health-care system during the unprecedented pandemic.
Video Player is loading.
Current Time 0:00
Duration 39:51
Loaded: 0%
Stream Type LIVE
Remaining Time 39:51
 
1x
  • Chapters
  • descriptions off, selected
  • en (Main), selected
Mike McNamara

Mike McNamara

Mike McNamara 是 NetApp 產品和解決方案行銷的資深主管,在資料管理和雲端儲存行銷領域擁有超過 25 年的豐富經驗。在十年前加入 NetApp 之前,Mike 曾任職於 Adaptec、Dell EMC 和 HPE 等公司。Mike 是推出第一方雲端儲存產品和業界第一款雲端連線 AI/ML 解決方案 (NetApp)、統一化橫向擴充和混合雲儲存系統與軟體 (NetApp)、iSCSI 和 SAS 儲存系統與軟體 (Adaptec),以及光纖通道儲存系統 (EMC CLARiiON) 的重要團隊領導者。此外他曾經擔任「光纖通道產業協會 (Fibre Channel Industry Association,FCIA)」的行銷主席,也是乙太網路技術高峰會議顧問委員會、乙太網路聯盟的成員,現在仍定期為業界期刊撰稿,並經常擔任活動講師。Mike 還透過 FriesenPress 出版了一本名為《橫向擴充儲存設備 - 企業資料管理的未來樣貌》的書籍,並被 Kapos 列為值得關注的 50 名 B2B 產品行銷人員。查看 Mike McNamara 的所有文章

後續步驟

Using AI to identify COVID-19 lesions in lung CT scans